Gavi fills its coffers for next five years
This article was originally published in Scrip
The Gavi global vaccine alliance has successfully concluded its second replenishment conference, securing the $7.5bn that it was targeting from donors including more than 20 countries, the European Commission and private sector partners and foundations including the Bill & Melinda Gates Foundation.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.